Myezom 2 mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Myezom 2 mg Injection contains bortezomib, a proteasome-inhibitor cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of patients with multiple myeloma and mantle-cell lymphoma. It is described as working to slow or stop the growth of cancer cells — by slowing the breakdown of proteins inside the cell, protein levels build up in the cancer cells and this leads to their death. It is administered only under healthcare guidance by a qualified medical professional, and the dose, interval, and duration of treatment are set by the doctor after assessment.
Product Information
The following description reflects information associated with bortezomib and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of multiple myeloma
- Described for the treatment of mantle-cell lymphoma
- Described as increasing protein levels inside cancer cells so that they stop growing and die
Described Dosage & Administration
- Given only by a doctor or nurse; it is not to be self-injected by a non-professional
- The dose, interval, and duration are decided by the doctor after a thorough assessment of the disease
- The doctor may request checks of heart, liver, and blood uric acid levels during treatment
Described Side Effects
Commonly described side effects include:
- Nausea and fatigue
- Fungal infection
- Anaemia (low number of red blood cells)
- Breathlessness
- Decreased white blood cell count (neutrophils and lymphocytes)
- Dehydration
- High blood pressure
- Itching and dry skin
- Low blood platelets
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- An updated medical history should be shared with the doctor to avoid any wrong medicine mix-up
- It is described as not for women who are pregnant or breastfeeding
- Every gender is advised to use effective contraception during treatment
- Common side effects such as nausea and fatigue that persist should be reported to the doctor immediately
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains bortezomib and is used for the treatment of multiple myeloma and mantle-cell lymphoma. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as given only by a qualified doctor or nurse under healthcare guidance. It is not for a non-professional to inject. The dose, interval, and duration are set by the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.